Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Parry

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|June 1, 1978
A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilliM F Parry, H C Neu
Chest|June 1, 1982
Aspergillus empyemaM F Parry, F R Coughlin, F X Zambetti
Antimicrobial Agents and Chemotherapy|July 1, 1988
Hepatobiliary kinetics and excretion of ciprofloxacinM F Parry, D A Smego, M A Digiovanni
Infection|January 1, 1978
Therapy of serious infections with cefamandoleM F Parry, M J Goldberger, H C Neu
Seminars in Respiratory Infections|December 1, 1987
The radiologic manifestations of Legionella pneumoniaR R Muder, V L Yu, M F Parry
The American Journal of Medicine|November 30, 1989
Quinolone resistance. Susceptibility data from a 300-bed community hospitalM F Parry, K B Panzer, M E Yukna
Infection Control and Hospital Epidemiology|January 4, 2008
Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals P C Carling, M F Parry, S M Von Beheren, et al.
AIDS Care|September 17, 2004
Collaborative management of HIV infection in the community: an effort to improve the quality of HIV careM F Parry, J Stewart, P Wright, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1984
Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibioticsM F Parry, B Jacobs, B Scully, et al.
Lancet (London, England)|April 12, 1986
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosaB E Scully, H C Neu, M F Parry, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|June 1, 1978
A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilliM F Parry, H C Neu
Chest|June 1, 1982
Aspergillus empyemaM F Parry, F R Coughlin, F X Zambetti
Antimicrobial Agents and Chemotherapy|July 1, 1988
Hepatobiliary kinetics and excretion of ciprofloxacinM F Parry, D A Smego, M A Digiovanni
Infection|January 1, 1978
Therapy of serious infections with cefamandoleM F Parry, M J Goldberger, H C Neu
Seminars in Respiratory Infections|December 1, 1987
The radiologic manifestations of Legionella pneumoniaR R Muder, V L Yu, M F Parry
The American Journal of Medicine|November 30, 1989
Quinolone resistance. Susceptibility data from a 300-bed community hospitalM F Parry, K B Panzer, M E Yukna
Infection Control and Hospital Epidemiology|January 4, 2008
Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals P C Carling, M F Parry, S M Von Beheren, et al.
AIDS Care|September 17, 2004
Collaborative management of HIV infection in the community: an effort to improve the quality of HIV careM F Parry, J Stewart, P Wright, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1984
Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibioticsM F Parry, B Jacobs, B Scully, et al.
Lancet (London, England)|April 12, 1986
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosaB E Scully, H C Neu, M F Parry, et al.
Pageof 5